Merrimack Pharmaceuticals
Patents, Design & Utilities

Last updated:

List of all Merrimack Pharmaceuticals patents 4 in total

Status Patent
Application
Utility: ANTI-TNFR2 ANTIBODIES AND USES THEREOF External link
Filling date: 5 Sep 2025 Issue date: 8 Sep 2022
Application
Utility: ANTI-TNFR2 ANTIBODIES AND USES THEREOF External link
Filling date: 5 Sep 2025 Issue date: 2 Dec 2021
Application
Utility: Nanoliposomal Targeting of Ephrin Receptor A2 (Epha2) and Related Diagnostics External link
Filling date: 5 Sep 2025 Issue date: 3 Oct 2019
Application
Utility: ANTIBODIES AGAINST THE ECTODOMAIN OF ERBB3 AND USES THEREOF External link
Filling date: 5 Sep 2025 Issue date: 26 Sep 2019

Showing 1 to 4 of 4 patents.